Leslie Carol Botha: Heidi Stevenson has written a brilliant researched article on why the marketing of the HPV vaccines is not justified. The science is there folks. Now you can make an informed decision on whether or not to vaccinate with Gardasil or Cervarix.
Brit Scientists Show HPV Vaccine Is Not Justified Anywhere
by Heidi Stevenson
A British study thoroughly condemns the claims made by Gates Foundation-related PACE to support HPV vaccines in India. Though not stated by the authors, it clearly shows that it makes no sense in western nations, either.
Just as it is in the west, the HPV vaccine is being heavily marketed in India. The heavy pressure to roll it out has resulted in tragic deaths of girls given the vaccines. Now, a report by the British Journal of the Royal Society of Medicine has come out with a study demonstrating that the HPV vaccines, Gardasil and Cervarix, cannot be justified in India. More scandalous, though, is that their results clearly reflect that these vaccines are even less justified in the western world, including the USA, UK, Europe, Canada, and Australia. That, though, is never mentioned in their report.
The primary point brought out by the study(1) is that the rate of cervical cancer is not high enough to justify the cost and risks associated with Gardasil and Cervarix vaccines. Further, the authors noted that the rate of cervical cancer in India has dropped dramatically in a little more than 20 years, from 43 cases per 100,000 in 1982-83 down to 22 per 100,000 in 2004-05. This point alone should clarify that the cause of cervical cancer is likely mostly associated with something that’s controllable in the environment. India’s standard of living has risen dramatically in the last 25 years, and that may be the most significant factor in cervical cancer rates.
The Program for Appropriate Technology in Health (PATH), which has close ties with the Bill Gates Foundation(2), is the primary force behind pushing HPV vaccines in India. Of course, Merck and GlaxoSmithKline (GSK) also actively push them because they manufacture the vaccines.
The British study has harsh words for the conclusions that PATH reached. They quote the PATH document, “Shaping a Strategy to Introduce HPV Vaccines in India, “Results from the HPV Vaccines’ states that ‘in raw numbers, India has the largest burden of cancer of the cervix of any country worldwide.” Then, they state:
This claim is not supported by the references, moreover data from the cancer registries in Gujarat or the Cancer Atlas were not cited.
PATH selected Andhra Pradesh and Gujarat ‘based on cervical cancer disease burden’ and because they were ‘in the middle range for certain variables (e.g., immunization coverage)’. There are no references provided for this statement.
Of the five studies that PATH cites in relation to cervical cancer or HPV epidemiology, one study could not be traced; the HBCR report is not comprehensive and does not provide age-adjusted cervical cancer incidence rates; and the three remaining studies did not examine epidemiology of cancer but reported on HPV prevalence and type distribution. Only one study was conducted in Andhra Pradesh and none in Gujarat. The three studies were conducted in rural populations in the south, and urban populations in the south and north of India.
In other words, the British study found that the claims made by PATH are not supported by any evidence!